Industry Research Reports

Home > Reports > Medical Devices & Consumables > Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-01-05

Pages: 115 Pages

Report ld: 5542646

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Transcutaneous Bilirubin Meters Research:CAGR of -0.3% during the forecast period

Transcutaneous Bilirubin Meters Market Size(US$)

CAGR 2026-2032

1.3%

Market Size,2032

USD 113

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 105 million

Market Forecast in 2032(Value)

US$ 113 million

CAGR

1.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Transcutaneous Bilirubin Meters cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.

In 2024, global Transcutaneous Bilirubin Meters reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.

Transcutaneous Bilirubin Meters are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.

Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.

The upstream core components of Transcutaneous Bilirubin Meters mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.

The single-line production capacity of Transcutaneous Bilirubin Meters varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.

Transcutaneous Bilirubin Meters are non-invasive sentinels protecting newborn health. Designed specifically for neonatal jaundice screening, these medical devices utilize spectral absorption technology. Simply place the probe lightly against the infant's forehead or sternum, and within seconds, the difference in reflection between blue and green light is used to calculate bilirubin levels, completely eliminating the pain and waiting associated with traditional blood tests. From bedside screening in maternity wards to routine monitoring in primary care hospitals and home follow-up, this device, with its non-invasive, rapid, and safe characteristics, has become a key tool for the early detection and intervention of neonatal hyperbilirubinemia, building the first line of defense for the health of millions of newborns worldwide.

The global market for Transcutaneous Bilirubin Meters exhibits a distinct regional development pattern. North America, relying on its mature neonatal healthcare system and high medical investment, has stable and concentrated market demand. Local companies have accumulated deep expertise in device intelligence and clinical adaptability, occupying a core position in the global market. Europe excels in technological precision, with stringent medical standards driving equipment upgrades towards low-interference, high-precision solutions. Products not only serve the well-developed local healthcare network but also radiate globally through technology exports. The Asia-Pacific region has become the core engine of industry growth. China, with its large newborn population and policies promoting the widespread availability of basic medical equipment, has propelled domestic brands from followers to leaders. Meanwhile, emerging markets such as India and Southeast Asia, with their improving healthcare infrastructure, are releasing strong incremental demand. According to our data, in 2024, Asia held nearly 50% of the market share for Transcutaneous Bilirubin Meters, followed by Europe and North America. During the forecast period, emerging markets such as India and Southeast Asia are leading the global growth rate.

From a manufacturer perspective, globally, key manufacturers of Transcutaneous Bilirubin Meters include Dräger, Mennen Medical, Philips, Konica Minolta, Beijing Maibang Optoelectronics, Ningbo Davy Medical, Weicai, AVI Healthcare, NEORUBIN (RECOVE GROUP), Nanjing Daofen Electronics, Likang Biotechnology, Boke Biotechnology, and Micro Lab. According to our data, the top 5 manufacturers accounted for over 70% of the global market share in 2024.

The convergence of multiple demands and policies has injected continuous growth momentum into the Transcutaneous Bilirubin Meters industry. The high incidence of neonatal jaundice forms a rigid demand foundation, while the monitoring needs of premature and high-risk infants further make the equipment a clinical necessity. At the policy level, countries are incorporating neonatal disease screening into their public health systems, while technological innovation is reshaping product value. Multi-wavelength spectral technology overcomes the bottleneck of skin color interference, and intelligent algorithms enable real-time data transmission and trend prediction, upgrading the equipment from a simple testing tool to an entry point for neonatal health management. Meanwhile, the public's growing preference for non-invasive medical care and increased awareness of home health monitoring have further broadened application scenarios, extending from hospitals to homes and forming a full-cycle monitoring ecosystem.

This report provides a comprehensive view of the global market for Transcutaneous Bilirubin Meters, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Transcutaneous Bilirubin Meters market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Transcutaneous Bilirubin Meters.

MARKET SEGMENTATION

By Company

Dräger
Mennen Medical
Philips
Konica Minolta
Beijing M&B Electronic Instruments
Ningbo David Medical Device
VECH MEDICAL
AVI Healthcare
NEORUBIN (RECOVE GROUP)
Dolphin Nanjing electronics
Heal Force
BIOBASE GROUP
Micro Lab

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Standard Type
Intelligent Type

Segment by Application

Hospitals
Clinics
Others

Segment by Category

Rechargeable Type
Non-rechargeable Type

Segment by Division

Single Measurement Optical Path
Dual Measurement Optical Path

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Transcutaneous Bilirubin Meters manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Transcutaneous Bilirubin Meters sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Transcutaneous Bilirubin Meters sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Transcutaneous Bilirubin Meters Product Introduction

1.2 Global Transcutaneous Bilirubin Meters Market Size Forecast

1.2.1 Global Transcutaneous Bilirubin Meters Sales Value (2021–2032)

1.2.2 Global Transcutaneous Bilirubin Meters Sales Volume (2021–2032)

1.2.3 Global Transcutaneous Bilirubin Meters Sales Price (2021–2032)

1.3 Transcutaneous Bilirubin Meters Market Trends & Drivers

1.3.1 Transcutaneous Bilirubin Meters Industry Trends

1.3.2 Transcutaneous Bilirubin Meters Market Drivers & Opportunities

1.3.3 Transcutaneous Bilirubin Meters Market Challenges

1.3.4 Transcutaneous Bilirubin Meters Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Transcutaneous Bilirubin Meters Players Revenue Ranking (2025)

2.2 Global Transcutaneous Bilirubin Meters Revenue by Company (2021–2026)

2.3 Global Transcutaneous Bilirubin Meters Sales Volume Ranking of Players (2025)

2.4 Global Transcutaneous Bilirubin Meters Sales Volume by Company (2021–2026)

2.5 Global Transcutaneous Bilirubin Meters Average Price by Company (2021–2026)

2.6 Key Manufacturers Transcutaneous Bilirubin Meters Manufacturing Base and Headquarters

2.7 Key Manufacturers Transcutaneous Bilirubin Meters Product Offerings

2.8 Key Manufacturers Start of Mass Production of Transcutaneous Bilirubin Meters

2.9 Transcutaneous Bilirubin Meters Market Competitive Analysis

2.9.1 Transcutaneous Bilirubin Meters Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Transcutaneous Bilirubin Meters Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Transcutaneous Bilirubin Meters revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Transcutaneous Bilirubin Meters Market Classification

3.1 Introduction by Type

3.1.1 Standard Type

3.1.2 Intelligent Type

3.1.3 Global Transcutaneous Bilirubin Meters Sales Value by Type

3.1.3.1 Global Transcutaneous Bilirubin Meters Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Transcutaneous Bilirubin Meters Sales Value, by Type (2021–2032)

3.1.3.3 Global Transcutaneous Bilirubin Meters Sales Value, by Type (%), 2021–2032

3.1.4 Global Transcutaneous Bilirubin Meters Sales Volume by Type

3.1.4.1 Global Transcutaneous Bilirubin Meters Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Transcutaneous Bilirubin Meters Sales Volume, by Type (2021–2032)

3.1.4.3 Global Transcutaneous Bilirubin Meters Sales Volume, by Type (%), 2021–2032

3.1.5 Global Transcutaneous Bilirubin Meters Average Price by Type (2021–2032)

3.2 Introduction by Power Supply Method

3.2.1 Rechargeable Type

3.2.2 Non-rechargeable Type

3.2.3 Global Transcutaneous Bilirubin Meters Sales Value by Power Supply Method

3.2.3.1 Global Transcutaneous Bilirubin Meters Sales Value by Power Supply Method (2021 vs 2025 vs 2032)

3.2.3.2 Global Transcutaneous Bilirubin Meters Sales Value, by Power Supply Method (2021–2032)

3.2.3.3 Global Transcutaneous Bilirubin Meters Sales Value, by Power Supply Method (%), 2021–2032

3.2.4 Global Transcutaneous Bilirubin Meters Sales Volume by Power Supply Method

3.2.4.1 Global Transcutaneous Bilirubin Meters Sales Volume by Power Supply Method (2021 vs 2025 vs 2032)

3.2.4.2 Global Transcutaneous Bilirubin Meters Sales Volume, by Power Supply Method (2021–2032)

3.2.4.3 Global Transcutaneous Bilirubin Meters Sales Volume, by Power Supply Method (%), 2021–2032

3.2.5 Global Transcutaneous Bilirubin Meters Average Price by Power Supply Method (2021–2032)

3.3 Introduction by Technology

3.3.1 Single Measurement Optical Path

3.3.2 Dual Measurement Optical Path

3.3.3 Global Transcutaneous Bilirubin Meters Sales Value by Technology

3.3.3.1 Global Transcutaneous Bilirubin Meters Sales Value by Technology (2021 vs 2025 vs 2032)

3.3.3.2 Global Transcutaneous Bilirubin Meters Sales Value, by Technology (2021–2032)

3.3.3.3 Global Transcutaneous Bilirubin Meters Sales Value, by Technology (%), 2021–2032

3.3.4 Global Transcutaneous Bilirubin Meters Sales Volume by Technology

3.3.4.1 Global Transcutaneous Bilirubin Meters Sales Volume by Technology (2021 vs 2025 vs 2032)

3.3.4.2 Global Transcutaneous Bilirubin Meters Sales Volume, by Technology (2021–2032)

3.3.4.3 Global Transcutaneous Bilirubin Meters Sales Volume, by Technology (%), 2021–2032

3.3.5 Global Transcutaneous Bilirubin Meters Average Price by Technology (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Others

4.2 Global Transcutaneous Bilirubin Meters Sales Value by Application

4.2.1 Global Transcutaneous Bilirubin Meters Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Transcutaneous Bilirubin Meters Sales Value, by Application (2021–2032)

4.2.3 Global Transcutaneous Bilirubin Meters Sales Value, by Application (%), 2021–2032

4.3 Global Transcutaneous Bilirubin Meters Sales Volume by Application

4.3.1 Global Transcutaneous Bilirubin Meters Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Transcutaneous Bilirubin Meters Sales Volume, by Application (2021–2032)

4.3.3 Global Transcutaneous Bilirubin Meters Sales Volume, by Application (%), 2021–2032

4.4 Global Transcutaneous Bilirubin Meters Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Transcutaneous Bilirubin Meters Sales Value by Region

5.1.1 Global Transcutaneous Bilirubin Meters Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Transcutaneous Bilirubin Meters Sales Value by Region (2021–2026)

5.1.3 Global Transcutaneous Bilirubin Meters Sales Value by Region (2027–2032)

5.1.4 Global Transcutaneous Bilirubin Meters Sales Value by Region (%), 2021–2032

5.2 Global Transcutaneous Bilirubin Meters Sales Volume by Region

5.2.1 Global Transcutaneous Bilirubin Meters Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Transcutaneous Bilirubin Meters Sales Volume by Region (2021–2026)

5.2.3 Global Transcutaneous Bilirubin Meters Sales Volume by Region (2027–2032)

5.2.4 Global Transcutaneous Bilirubin Meters Sales Volume by Region (%), 2021–2032

5.3 Global Transcutaneous Bilirubin Meters Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Transcutaneous Bilirubin Meters Sales Value, 2021–2032

5.4.2 North America Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Transcutaneous Bilirubin Meters Sales Value, 2021–2032

5.5.2 Europe Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Transcutaneous Bilirubin Meters Sales Value, 2021–2032

5.6.2 Asia Pacific Transcutaneous Bilirubin Meters Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Transcutaneous Bilirubin Meters Sales Value, 2021–2032

5.7.2 South America Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Transcutaneous Bilirubin Meters Sales Value, 2021–2032

5.8.2 Middle East & Africa Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Transcutaneous Bilirubin Meters Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Transcutaneous Bilirubin Meters Sales Value and Sales Volume

6.2.1 Key Countries/Regions Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.2.2 Key Countries/Regions Transcutaneous Bilirubin Meters Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.3.2 United States Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.4.2 Europe Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.5.2 China Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.5.3 China Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.6.2 Japan Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.7.2 South Korea Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.8.2 Southeast Asia Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Transcutaneous Bilirubin Meters Sales Value, 2021–2032

6.9.2 India Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

6.9.3 India Transcutaneous Bilirubin Meters Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Dräger

7.1.1 Dräger Company Information

7.1.2 Dräger Introduction and Business Overview

7.1.3 Dräger Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Dräger Transcutaneous Bilirubin Meters Product Offerings

7.1.5 Dräger Recent Developments

7.2 Mennen Medical

7.2.1 Mennen Medical Company Information

7.2.2 Mennen Medical Introduction and Business Overview

7.2.3 Mennen Medical Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Mennen Medical Transcutaneous Bilirubin Meters Product Offerings

7.2.5 Mennen Medical Recent Developments

7.3 Philips

7.3.1 Philips Company Information

7.3.2 Philips Introduction and Business Overview

7.3.3 Philips Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Philips Transcutaneous Bilirubin Meters Product Offerings

7.3.5 Philips Recent Developments

7.4 Konica Minolta

7.4.1 Konica Minolta Company Information

7.4.2 Konica Minolta Introduction and Business Overview

7.4.3 Konica Minolta Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Konica Minolta Transcutaneous Bilirubin Meters Product Offerings

7.4.5 Konica Minolta Recent Developments

7.5 Beijing M&B Electronic Instruments

7.5.1 Beijing M&B Electronic Instruments Company Information

7.5.2 Beijing M&B Electronic Instruments Introduction and Business Overview

7.5.3 Beijing M&B Electronic Instruments Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Beijing M&B Electronic Instruments Transcutaneous Bilirubin Meters Product Offerings

7.5.5 Beijing M&B Electronic Instruments Recent Developments

7.6 Ningbo David Medical Device

7.6.1 Ningbo David Medical Device Company Information

7.6.2 Ningbo David Medical Device Introduction and Business Overview

7.6.3 Ningbo David Medical Device Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Ningbo David Medical Device Transcutaneous Bilirubin Meters Product Offerings

7.6.5 Ningbo David Medical Device Recent Developments

7.7 VECH MEDICAL

7.7.1 VECH MEDICAL Company Information

7.7.2 VECH MEDICAL Introduction and Business Overview

7.7.3 VECH MEDICAL Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 VECH MEDICAL Transcutaneous Bilirubin Meters Product Offerings

7.7.5 VECH MEDICAL Recent Developments

7.8 AVI Healthcare

7.8.1 AVI Healthcare Company Information

7.8.2 AVI Healthcare Introduction and Business Overview

7.8.3 AVI Healthcare Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 AVI Healthcare Transcutaneous Bilirubin Meters Product Offerings

7.8.5 AVI Healthcare Recent Developments

7.9 NEORUBIN (RECOVE GROUP)

7.9.1 NEORUBIN (RECOVE GROUP) Company Information

7.9.2 NEORUBIN (RECOVE GROUP) Introduction and Business Overview

7.9.3 NEORUBIN (RECOVE GROUP) Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 NEORUBIN (RECOVE GROUP) Transcutaneous Bilirubin Meters Product Offerings

7.9.5 NEORUBIN (RECOVE GROUP) Recent Developments

7.10 Dolphin Nanjing electronics

7.10.1 Dolphin Nanjing electronics Company Information

7.10.2 Dolphin Nanjing electronics Introduction and Business Overview

7.10.3 Dolphin Nanjing electronics Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Dolphin Nanjing electronics Transcutaneous Bilirubin Meters Product Offerings

7.10.5 Dolphin Nanjing electronics Recent Developments

7.11 Heal Force

7.11.1 Heal Force Company Information

7.11.2 Heal Force Introduction and Business Overview

7.11.3 Heal Force Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 Heal Force Transcutaneous Bilirubin Meters Product Offerings

7.11.5 Heal Force Recent Developments

7.12 BIOBASE GROUP

7.12.1 BIOBASE GROUP Company Information

7.12.2 BIOBASE GROUP Introduction and Business Overview

7.12.3 BIOBASE GROUP Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.12.4 BIOBASE GROUP Transcutaneous Bilirubin Meters Product Offerings

7.12.5 BIOBASE GROUP Recent Developments

7.13 Micro Lab

7.13.1 Micro Lab Company Information

7.13.2 Micro Lab Introduction and Business Overview

7.13.3 Micro Lab Transcutaneous Bilirubin Meters Sales, Revenue, Price and Gross Margin (2021–2026)

7.13.4 Micro Lab Transcutaneous Bilirubin Meters Product Offerings

7.13.5 Micro Lab Recent Developments

8 Industry Chain Analysis

8.1 Transcutaneous Bilirubin Meters Industrial Chain

8.2 Transcutaneous Bilirubin Meters Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Transcutaneous Bilirubin Meters Sales Model

8.5.2 Sales Channels

8.5.3 Transcutaneous Bilirubin Meters Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Transcutaneous Bilirubin Meters Market Trends

Table 2. Transcutaneous Bilirubin Meters Market Drivers & Opportunities

Table 3. Transcutaneous Bilirubin Meters Market Challenges

Table 4. Transcutaneous Bilirubin Meters Market Restraints

List of Figures

Figure 1. Transcutaneous Bilirubin Meters Product Picture

Figure 2. Global Transcutaneous Bilirubin Meters Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 4. Global Transcutaneous Bilirubin Meters Sales Volume (K Units), 2021–2032

Figure 5. Global Transcutaneous Bilirubin Meters Sales Price (US$/Unit), 2021–2032

Figure 6. Transcutaneous Bilirubin Meters Report Years Considered

Figure 7. Global Transcutaneous Bilirubin Meters Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Transcutaneous Bilirubin Meters Sales Volume Ranking of Players (K Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Transcutaneous Bilirubin Meters Revenue in 2025

Figure 10. Transcutaneous Bilirubin Meters Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Standard Type Picture

Figure 12. Intelligent Type Picture

Figure 13. Global Transcutaneous Bilirubin Meters Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Transcutaneous Bilirubin Meters Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Transcutaneous Bilirubin Meters Sales Volume by Type (K Units), 2021 vs 2025 vs 2032

Figure 16. Global Transcutaneous Bilirubin Meters Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Transcutaneous Bilirubin Meters Price by Type (US$/Unit), 2021–2032

Figure 18. Rechargeable Type Picture

Figure 19. Non-rechargeable Type Picture

Figure 20. Global Transcutaneous Bilirubin Meters Sales Value by Power Supply Method (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Transcutaneous Bilirubin Meters Sales Value Market Share by Power Supply Method, 2025 & 2032

Figure 22. Global Transcutaneous Bilirubin Meters Sales Volume by Power Supply Method (K Units), 2021 vs 2025 vs 2032

Figure 23. Global Transcutaneous Bilirubin Meters Sales Volume Market Share by Power Supply Method, 2025 & 2032

Figure 24. Global Transcutaneous Bilirubin Meters Price by Power Supply Method (US$/Unit), 2021–2032

Figure 25. Single Measurement Optical Path Picture

Figure 26. Dual Measurement Optical Path Picture

Figure 27. Global Transcutaneous Bilirubin Meters Sales Value by Technology (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Transcutaneous Bilirubin Meters Sales Value Market Share by Technology, 2025 & 2032

Figure 29. Global Transcutaneous Bilirubin Meters Sales Volume by Technology (K Units), 2021 vs 2025 vs 2032

Figure 30. Global Transcutaneous Bilirubin Meters Sales Volume Market Share by Technology, 2025 & 2032

Figure 31. Global Transcutaneous Bilirubin Meters Price by Technology (US$/Unit), 2021–2032

Figure 32. Product Picture of Hospitals

Figure 33. Product Picture of Clinics

Figure 34. Product Picture of Others

Figure 35. Global Transcutaneous Bilirubin Meters Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 36. Global Transcutaneous Bilirubin Meters Sales Value Market Share by Application, 2025 & 2032

Figure 37. Global Transcutaneous Bilirubin Meters Sales Volume by Application (K Units), 2021 vs 2025 vs 2032

Figure 38. Global Transcutaneous Bilirubin Meters Sales Volume Market Share by Application, 2025 & 2032

Figure 39. Global Transcutaneous Bilirubin Meters Price by Application (US$/Unit), 2021–2032

Figure 40. North America Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 41. North America Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

Figure 42. Europe Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 43. Europe Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

Figure 44. Asia Pacific Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 45. Asia Pacific Transcutaneous Bilirubin Meters Sales Value by Region (%), 2025 vs 2032

Figure 46. South America Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 47. South America Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

Figure 48. Middle East & Africa Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 49. Middle East & Africa Transcutaneous Bilirubin Meters Sales Value by Country (%), 2025 vs 2032

Figure 50. Key Countries/Regions Transcutaneous Bilirubin Meters Sales Value (%), 2021–2032

Figure 51. Key Countries/Regions Transcutaneous Bilirubin Meters Sales Volume (%), 2021–2032

Figure 52. United States Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 53. United States Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 54. United States Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 55. Europe Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 56. Europe Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 57. Europe Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 58. China Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 59. China Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 60. China Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 61. Japan Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 62. Japan Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 63. Japan Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 64. South Korea Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 65. South Korea Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 66. South Korea Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 67. Southeast Asia Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 68. Southeast Asia Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 69. Southeast Asia Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 70. India Transcutaneous Bilirubin Meters Sales Value (US$ Million), 2021–2032

Figure 71. India Transcutaneous Bilirubin Meters Sales Value by Type (%), 2025 vs 2032

Figure 72. India Transcutaneous Bilirubin Meters Sales Value by Application (%), 2025 vs 2032

Figure 73. Transcutaneous Bilirubin Meters Industrial Chain

Figure 74. Transcutaneous Bilirubin Meters Manufacturing Cost Structure

Figure 75. Channels of Distribution (Direct Sales, and Distribution)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Transcutaneous Bilirubin Meters market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Transcutaneous Bilirubin Meters market is 1.3% 2026 to 2032.

Which companies rank high in the global Transcutaneous Bilirubin Meters market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Transcutaneous Bilirubin Meters in 2026? shouQi

What was the global market size of Transcutaneous Bilirubin Meters in 2032? shouQi

Related Reports

Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Transcutaneous Bilirubin Meters market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 99
USD 4250.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2026
The global Transcutaneous Bilirubin Meters market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
Transcutaneous Bilirubin Meters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 107.05 million in 2024 and is forecast to a readjusted size of US$ 103.09 million by 2031 with a CAGR of -0.30% during the forecast period 2025-2031.
Published Date: 2025-12-01
Pages: 178
USD 3950.00
(Single User License)
Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transcutaneous Bilirubin Meters market size was US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 102
USD 4250.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Transcutaneous Bilirubin Meters market is projected to grow from US$ 101 million in 2024 to US$ 122 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 175
USD 4900.00
(Single User License)
Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 144
USD 3950.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2025
The global market for Transcutaneous Bilirubin Meters was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-01-13
Pages: 103
USD 2900.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Insights, Forecast to 2030
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published Date: 2024-04-28
Pages: 112
USD 4900.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2024
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published Date: 2024-02-05
Pages: 97
USD 2900.00
(Single User License)

Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Transcutaneous Bilirubin Meters market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 99
USD 4250.00 (Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2026
The global Transcutaneous Bilirubin Meters market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
USD 2900.00 (Single User License)
Transcutaneous Bilirubin Meters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 107.05 million in 2024 and is forecast to a readjusted size of US$ 103.09 million by 2031 with a CAGR of -0.30% during the forecast period 2025-2031.
Published: 2025-12-01
Pages: 178
USD 3950.00 (Single User License)
Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transcutaneous Bilirubin Meters market size was US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 102
USD 4250.00 (Single User License)
Global Transcutaneous Bilirubin Meters Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Transcutaneous Bilirubin Meters market is projected to grow from US$ 101 million in 2024 to US$ 122 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 175
USD 4900.00 (Single User License)
Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 144
USD 3950.00 (Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2025
The global market for Transcutaneous Bilirubin Meters was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-01-13
Pages: 103
USD 2900.00 (Single User License)
Global Transcutaneous Bilirubin Meters Market Insights, Forecast to 2030
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published: 2024-04-28
Pages: 112
USD 4900.00 (Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2024
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published: 2024-02-05
Pages: 97
USD 2900.00 (Single User License)